Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (9)
  • Open Access

    ARTICLE

    SwinHCAD: A Robust Multi-Modality Segmentation Model for Brain Tumors Using Transformer and Channel-Wise Attention

    Seyong Jin1, Muhammad Fayaz2, L. Minh Dang3, Hyoung-Kyu Song3, Hyeonjoon Moon2,*

    CMC-Computers, Materials & Continua, Vol.86, No.1, pp. 1-23, 2026, DOI:10.32604/cmc.2025.070667 - 10 November 2025

    Abstract Brain tumors require precise segmentation for diagnosis and treatment plans due to their complex morphology and heterogeneous characteristics. While MRI-based automatic brain tumor segmentation technology reduces the burden on medical staff and provides quantitative information, existing methodologies and recent models still struggle to accurately capture and classify the fine boundaries and diverse morphologies of tumors. In order to address these challenges and maximize the performance of brain tumor segmentation, this research introduces a novel SwinUNETR-based model by integrating a new decoder block, the Hierarchical Channel-wise Attention Decoder (HCAD), into a powerful SwinUNETR encoder. The HCAD… More >

  • Open Access

    REVIEW

    Pharmacological Phase I Clinical Trials in Pediatric Brain Tumors (1990–2024): A Historical Perspective

    Rosa Scarpitta1,#, Emiliano Cappello1,#, Alice Cangialosi1, Veronica Gori1, Giulia De Luca1,2, Giovanni Gori3, Guido Bocci1,*

    Oncology Research, Vol.33, No.10, pp. 2603-2656, 2025, DOI:10.32604/or.2025.066260 - 26 September 2025

    Abstract Central nervous system (CNS) tumors are the most common solid tumors in pediatric patients and the leading cause of childhood cancer-related mortality. Their rarity compared to adult cancers has made enrolling sufficient cases for clinical trials challenging. Consequently, pediatric CNS tumors were long treated with adult protocols despite distinct biological and clinical characteristics. This review examines key aspects of phase I pediatric oncology trials, including study design, primary outcomes, and pharmacological approaches, along with secondary considerations like clinical responses and ethical aspects. Firstly, we evaluated all phase I trial protocols focusing on pediatric CNS tumors… More > Graphic Abstract

    Pharmacological Phase I Clinical Trials in Pediatric Brain Tumors (1990–2024): A Historical Perspective

  • Open Access

    REVIEW

    Engendered nanoparticles for treatment of brain tumors

    SOROUSH SOLEYMANI1, MOHAMMAD DOROUDIAN2,*, MAHDIEH SOEZI3,4, ALI BELADI5, KIARASH ASGARI2, ASO MOBARAKSHAHI2, ARYANA AGHAEIPOUR2, RONAN MACLOUGHLIN6,7,8,*

    Oncology Research, Vol.33, No.1, pp. 15-26, 2025, DOI:10.32604/or.2024.053069 - 20 December 2024

    Abstract Brain metastasis and primary glioblastoma multiforme represent the most common and lethal malignant brain tumors. Its median survival time is typically less than a year after diagnosis. One of the major challenges in treating these cancers is the efficiency of the transport of drugs to the central nervous system. The blood-brain barrier is cooperating with advanced stages of malignancy. The blood-brain barrier poses a significant challenge to delivering systemic medications to brain tumors. Nanodrug delivery systems have emerged as promising tools for effectively crossing this barrier. Additionally, the development of smart nanoparticles brings new hope More >

  • Open Access

    REVIEW

    Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier

    KARAN WADHWA1, PAYAL CHAUHAN1, SHOBHIT KUMAR2, RAKESH PAHWA3,*, RAVINDER VERMA4, RAJAT GOYAL5, GOVIND SINGH1, ARCHANA SHARMA6, NEHA RAO3, DEEPAK KAUSHIK1,*

    Oncology Research, Vol.32, No.5, pp. 877-897, 2024, DOI:10.32604/or.2024.047278 - 23 April 2024

    Abstract Background: Glioblastoma multiforme (GBM) is recognized as the most lethal and most highly invasive tumor. The high likelihood of treatment failure arises from the presence of the blood-brain barrier (BBB) and stem cells around GBM, which avert the entry of chemotherapeutic drugs into the tumor mass. Objective: Recently, several researchers have designed novel nanocarrier systems like liposomes, dendrimers, metallic nanoparticles, nanodiamonds, and nanorobot approaches, allowing drugs to infiltrate the BBB more efficiently, opening up innovative avenues to prevail over therapy problems and radiation therapy. Methods: Relevant literature for this manuscript has been collected from a comprehensive More > Graphic Abstract

    Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier

  • Open Access

    ARTICLE

    Advancing Brain Tumor Analysis through Dynamic Hierarchical Attention for Improved Segmentation and Survival Prognosis

    S. Kannan1,*, S. Anusuya2

    CMC-Computers, Materials & Continua, Vol.77, No.3, pp. 3835-3851, 2023, DOI:10.32604/cmc.2023.042465 - 26 December 2023

    Abstract Gliomas, the most prevalent primary brain tumors, require accurate segmentation for diagnosis and risk assessment. In this paper, we develop a novel deep learning-based method, the Dynamic Hierarchical Attention for Improved Segmentation and Survival Prognosis (DHA-ISSP) model. The DHA-ISSP model combines a three-band 3D convolutional neural network (CNN) U-Net architecture with dynamic hierarchical attention mechanisms, enabling precise tumor segmentation and survival prediction. The DHA-ISSP model captures fine-grained details and contextual information by leveraging attention mechanisms at multiple levels, enhancing segmentation accuracy. By achieving remarkable results, our approach surpasses 369 competing teams in the 2020 Multimodal… More >

  • Open Access

    ARTICLE

    Classification of Brain Tumors Using Hybrid Feature Extraction Based on Modified Deep Learning Techniques

    Tawfeeq Shawly1, Ahmed Alsheikhy2,*

    CMC-Computers, Materials & Continua, Vol.77, No.1, pp. 425-443, 2023, DOI:10.32604/cmc.2023.040561 - 31 October 2023

    Abstract According to the World Health Organization (WHO), Brain Tumors (BrT) have a high rate of mortality across the world. The mortality rate, however, decreases with early diagnosis. Brain images, Computed Tomography (CT) scans, Magnetic Resonance Imaging scans (MRIs), segmentation, analysis, and evaluation make up the critical tools and steps used to diagnose brain cancer in its early stages. For physicians, diagnosis can be challenging and time-consuming, especially for those with little expertise. As technology advances, Artificial Intelligence (AI) has been used in various domains as a diagnostic tool and offers promising outcomes. Deep-learning techniques are… More >

  • Open Access

    ARTICLE

    Novel Framework of Segmentation 3D MRI of Brain Tumors

    Ibrahim Mahmoud El-Henawy1, Mostafa Elbaz2, Zainab H. Ali3,*, Noha Sakr4

    CMC-Computers, Materials & Continua, Vol.74, No.2, pp. 3489-3502, 2023, DOI:10.32604/cmc.2023.033356 - 31 October 2022

    Abstract Medical image segmentation is a crucial process for computer-aided diagnosis and surgery. Medical image segmentation refers to portioning the images into small, disjointed parts for simplifying the processes of analysis and examination. Rician and speckle noise are different types of noise in magnetic resonance imaging (MRI) that affect the accuracy of the segmentation process negatively. Therefore, image enhancement has a significant role in MRI segmentation. This paper proposes a novel framework that uses 3D MRI images from Kaggle and applies different diverse models to remove Rician and speckle noise using the best possible noise-free image.… More >

  • Open Access

    REVIEW

    The Integrated Histopathologic and Molecular Approach to Adult-type Diffuse Astrocytomas: Status of the Art, Based on the 2021 WHO Classification of Central Nervous System Tumors

    Hiba Alzoubi1, Alameen Alsabbah2, Rosario Caltabiano3, Giuseppe Broggi3,*

    Oncologie, Vol.24, No.1, pp. 51-63, 2022, DOI:10.32604/oncologie.2022.020890 - 31 March 2022

    Abstract The 2021 World Health Organization (WHO) Classification of Tumors of the Central Nervous System (CNS) improved our understanding of the brain neoplasm biology. In more details, differences between diffuse gliomas that primarily occur in adults and those that primarily occur in children have been identified by the terms “adult-type” and “pediatric-type” diffuse gliomas. More importantly, both diagnostic and grading criteria for adult-type diffuse astrocytomas have been modified, by adopting novel molecular markers: diffuse astrocytomas, IDH-mutant have been grouped into a single entity and graded as CNS WHO grades 2, 3, or 4, with the assignment of More >

  • Open Access

    ARTICLE

    AGWO-CNN Classification for Computer-Assisted Diagnosis of Brain Tumors

    T. Jeslin1,*, J. Arul Linsely2

    CMC-Computers, Materials & Continua, Vol.71, No.1, pp. 171-182, 2022, DOI:10.32604/cmc.2022.020255 - 03 November 2021

    Abstract Brain cancer is the premier reason for cancer deaths all over the world. The diagnosis of brain cancer at an initial stage is mediocre, as the radiologist is ineffectual. Different experiments have been conducted and demonstrated clearly that the algorithms for nodule segmentation are unsuccessful. Therefore, the research has consolidated incremental clustering focused on superpixel segmentation as an appropriate optimization approach for the accurate segmentation of pulmonary nodules. The key aim of the research is to refine brain CT images to accurately distinguish tumors and the segmentation of small-scale anomalous nodules in the brain region.… More >

Displaying 1-10 on page 1 of 9. Per Page